October 15, 2021
Rose
But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.
from NYT > Health https://ift.tt/3BO1uUQ
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment